Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does REGORAFENIB\REGORAFENIB Cause Dysphonia? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Dysphonia have been filed in association with REGORAFENIB\REGORAFENIB. This represents 6.6% of all adverse event reports for REGORAFENIB\REGORAFENIB.

7
Reports of Dysphonia with REGORAFENIB\REGORAFENIB
6.6%
of all REGORAFENIB\REGORAFENIB reports
2
Deaths
3
Hospitalizations

How Dangerous Is Dysphonia From REGORAFENIB\REGORAFENIB?

Of the 7 reports, 2 (28.6%) resulted in death, 3 (42.9%) required hospitalization.

Is Dysphonia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for REGORAFENIB\REGORAFENIB. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does REGORAFENIB\REGORAFENIB Cause?

Off label use (40) Fatigue (18) Death (17) Asthenia (15) Diarrhoea (11) Decreased appetite (10) Pain in extremity (9) Palmar-plantar erythrodysaesthesia syndrome (9) Constipation (8) Weight decreased (7)

What Other Drugs Cause Dysphonia?

FLUTICASONE\SALMETEROL (1,729) CABOZANTINIB S-MALATE (1,229) ADALIMUMAB (1,216) BUDESONIDE\FORMOTEROL (1,204) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (1,143) ALBUTEROL (1,114) LENVATINIB (1,021) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (943) LENALIDOMIDE (931) AMIKACIN (914)

Which REGORAFENIB\REGORAFENIB Alternatives Have Lower Dysphonia Risk?

REGORAFENIB\REGORAFENIB vs RELATLIMAB REGORAFENIB\REGORAFENIB vs RELPAX REGORAFENIB\REGORAFENIB vs RELUGOLIX REGORAFENIB\REGORAFENIB vs REMDESIVIR REGORAFENIB\REGORAFENIB vs REMERON

Related Pages

REGORAFENIB\REGORAFENIB Full Profile All Dysphonia Reports All Drugs Causing Dysphonia REGORAFENIB\REGORAFENIB Demographics